Home non-invasive ventilation (NIV) is frequently implemented to correct nocturnal alveolar hypoventilation in a number of chronic respiratory diseases. The most widely used ventilator mode is pressure-support (PS) ventilation with a backup respiratory rate spontaneous timed (ST) mode.
Changing lifestyle pattern, high consumption of unhealthy food is resulting in rise in number of patients suffering from breathing and lungs problems. Diagnosis of COPD is seen commonly among young and old age population. High consumption of tobacco in developed & developing countries, rise in number of patients in hospitals suffering from breathing problems, coupled with approach towards home healthcare are factors increasing demand for ventilators. More than 65 million people around the world have moderate or severe COPD. It is a leading cause of death in the United States, affecting 16 million Americans. Due to availability of advanced healthcare infrastructure in developed countries adoption of advanced medical devices is increasing.
High spending capacity and availability of favorable reimbursement policies is driving old age consumer’s preference towards home healthcare. Spending for home health care agencies increased 4.3% in 2017, the same rate as 2016, to US$ 97.0 Bn. These cumulative factors are increasing demand for household non-invasive ventilator. Rapid technological advancements are carried out by medical device manufactures in order to deliver more advanced product for better care. High investment for R&D activities and focus on introduction of innovative products are factors impacting the growth of household non-invasive ventilators market.
In 2020, SpiceJet launched a portable, non-invasive ventilation device ‘SpiceOxy’ developed by SpiceJet Technic in the wake of coronavirus. The product was launched for patients with mild to moderate breathing issues..
Rising pandemic effect across the globe and government of countries in collaboration with private players focused on development of innovative solutions are factors expected to boost the growth of household non-invasive ventilators market. In 2020, Nanotronics Health, LLC a medical device manufacturer, received an emergency use authorization (EUA) from the U.S. Food & Drug Administration (FDA) for its non-invasive ventilator, nHale, for at-home use. Factors such as high cost of device and stringent government regulations related to product approval are expected to hamper the growth of global household non-invasive ventilators market.
In addition, lack of infrastructure availability in developing countries is expected to challenge the growth of target market. However, increasing investment by major players for product development, integration of advanced analytical solutions in order to improve the product output and focus on online sale channel are factors expected to create new opportunities for players operating in the global household non-invasive ventilators market. In addition, partnership and merger activities in order to enhance the business are factors expected to support the revenue growth of the target market.
Segment Analysis by Region
The market in North America is expected to account for major revenue share in the global household non-invasive ventilators market due to high patient pool suffering from COPD. In addition, favorable reimbursement policies by the government and preference for home healthcare among consumers are factors expected to increase demand for household non-invasive ventilators. Moreover, factor such as presence of large number of players operating in the country and focus on introduction of innovative solutions is expected to impact the growth of regional market.
The market in Asia Pacific is expected to witness faster growth in the household non-invasive ventilators market due to changing government norms towards healthcare service offering. Rise in consumer awareness related to home care and availability of advanced portable medical devices, and high spending on healthcare are factors expected to impact the growth of target market in this region. In addition, emergence of small and mid-size enterprises with innovative products will boost the growth of household non-invasive ventilators market.
The global household non-invasive ventilators market is high highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition. The players profiled in the report are ResMed, Teijin Pharma, DeVilbiss Healthcare, Philips Healthcare, Löwenstein Medical, Fisher and Paykel Healthcare, Medtronic plc, Apex Medical Corp., Breas Medical AB, and Koike Medical.
Household Non-Invasive Ventilators Market Segment Analysis, 2020
The global household non-invasive ventilators market is segmented into product, application, and sales channels. The product segment is bifurcated into electric, pneumatic, and electro-pneumatic. The electric segment among the product type is expected to account for a noticeable revenue share in the global household non-invasive ventilators market. The sales channel segment is divided into online and offline. Among sales channels, the online segment is expected to witness faster growth in the target market.
Market By Product
Market By Age Group
Less than 30 years old
30 to 60 years old
More than 60years old
Market By Sales Channel
Market By Geography
• Rest of Europe
• South Korea
• Rest of Asia-Pacific
• Rest of Latin America
Middle East & Africa
• South Africa
• Rest of Middle East & Africa
Rising pandemic effect across the globe and government of countries in collaboration with private players is focused on development of innovative solutions this factor is expected to boost the growth of household non-invasive ventilators market.
In age group, the more than 60years old segment is growing at faster pace.
In the global market the Asia Pacific region is expected to grow faster.
Some of the players considered in the report scope are ResMed, Teijin Pharma, DeVilbiss Healthcare, Philips Healthcare, Löwenstein Medical, and Fisher & Paykel Healthcare.
The North America is expected to account for major revenue share in the global market.
In sales channel online segment is growing at faster pace.
Factors such as high cost of device and stringent government regulations related to product approval are expected to hamper the growth of global household non-invasive ventilators market.